ATE141165T1 - Verwendung von 4-mercapto-6-hydroxy-pyrazolo(4,3- d)-pyrimidine als radikalfänger - Google Patents

Verwendung von 4-mercapto-6-hydroxy-pyrazolo(4,3- d)-pyrimidine als radikalfänger

Info

Publication number
ATE141165T1
ATE141165T1 AT90400081T AT90400081T ATE141165T1 AT E141165 T1 ATE141165 T1 AT E141165T1 AT 90400081 T AT90400081 T AT 90400081T AT 90400081 T AT90400081 T AT 90400081T AT E141165 T1 ATE141165 T1 AT E141165T1
Authority
AT
Austria
Prior art keywords
mercapto
pyrimidine
pyrazolo
hydroxy
caugger
Prior art date
Application number
AT90400081T
Other languages
English (en)
Inventor
Belinda Pierce
Original Assignee
Bouchara Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bouchara Sa filed Critical Bouchara Sa
Application granted granted Critical
Publication of ATE141165T1 publication Critical patent/ATE141165T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90400081T 1989-01-11 1990-01-11 Verwendung von 4-mercapto-6-hydroxy-pyrazolo(4,3- d)-pyrimidine als radikalfänger ATE141165T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8900353A FR2641465A1 (fr) 1989-01-11 1989-01-11 Nouveau capteur de radicaux libres et les compositions pharmaceutiques en contenant

Publications (1)

Publication Number Publication Date
ATE141165T1 true ATE141165T1 (de) 1996-08-15

Family

ID=9377685

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90400081T ATE141165T1 (de) 1989-01-11 1990-01-11 Verwendung von 4-mercapto-6-hydroxy-pyrazolo(4,3- d)-pyrimidine als radikalfänger

Country Status (4)

Country Link
EP (1) EP0378483B1 (de)
AT (1) ATE141165T1 (de)
DE (1) DE69028024D1 (de)
FR (1) FR2641465A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1251838B (it) * 1991-09-20 1995-05-26 Lpb Ist Farm Uso della nimesulide nel trattamento della cataratta

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3141M (fr) * 1962-05-23 1965-02-22 Wellcome Found Médicament a base d'un dérivé de pyrazolo [3.4-d] pyrimidine.
US3474098A (en) * 1968-08-22 1969-10-21 Burroughs Wellcome Co Pyrazolo-(3,4-d) pyrimidines
ZA871813B (en) * 1986-03-13 1988-10-26 Wellcome Found Cell protection
FR2608045B1 (fr) * 1986-12-12 1990-03-02 Chauvin Laboratoires Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome

Also Published As

Publication number Publication date
EP0378483A2 (de) 1990-07-18
EP0378483B1 (de) 1996-08-14
DE69028024D1 (de) 1996-09-19
EP0378483A3 (de) 1991-09-11
FR2641465A1 (fr) 1990-07-13

Similar Documents

Publication Publication Date Title
FI862434A0 (fi) Foerfarande foer framstaellning av difluor-ketonpeptidderivat.
AU4732989A (en) Pyrimidines and their pharmaceutical acceptable salts thereof, and their use as medicines
EE02995B1 (et) 1,3-oksatiolaannukleosiidi analoogide kasutamine hepatiit B ravimpreparaatide valmistamiseks
DE69223914D1 (de) 4-substituierte-2-Deoxy-2,3-Didehydro Alpha-D-Neuraminsäure antivirale Derivate
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
DE3883016D1 (de) Komplexe verbindungen aus bioflavonoiden mit phospholipiden, ihre herstellung und verwendung und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
ATE142877T1 (de) Melatoninderivate zur behandlung von schlafstörungen und zur pre-anästhesie
DK602988A (da) Nukleosidderivater med antiviral virkning og laegemiddelpraeparat indeholdende saadanne forbindelser
ZA879464B (en) Pharmaceutical compositions
AU1272788A (en) Use of metformin in the preparation of medicines
DE69704619D1 (de) Bisaromatische verbindungen, sie enthaltende pharmazeutische und kosmetische zusammensetzungen und verwendungen
EP0344880A3 (en) Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer
ATE99953T1 (de) Antivirales kombinationspraeparat.
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
ZA949332B (en) Use of 1-{4-[4-aryl(or heteroaryl)-1-piperazinyl]-butyl}-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion
ES2102772T3 (es) Compuesto citotoxico y antiviral.
DE69028024D1 (de) Verwendung von 4-Mercapto-6-hydroxy-pyrazolo(4,3-d)-pyrimidine als Radikalfänger
IL148739A0 (en) 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use
DE69306990D1 (de) Physostigmin-Derivate, ihre Verwendung und sie enthaltende pharmazeutische Formulierungen
SI0948967T1 (en) Treatment of viral disease in swine
FR2694005B1 (fr) Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
HU9403783D0 (en) Use of bradykinin-antagonists for producing pharmaceutical compositions for treating virus diseases
DE69233793D1 (de) Pharmazeutische Zusammensetzung zur Verwendung in der Behandlung von Eierstockkrebs
DK0950053T3 (da) Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater
DE69131521D1 (de) Alpha-Ergocryptine enthaltende pharmazeutische Zusammensetzungen mit nervenschützender Wirkung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties